The trademark CZ BIOHUB was filed by Chan Zuckerberg Initiative, LLC, a Limited Liability Company (the "Applicant"). The application was published for oppositions on May 11, 2020, and received undefined oppositions.
Opposition Proceedings
There are undefined Oppositions claimed against trademark.
The first opposition filed on August 11, 2020 by BIOM'UP on Likelihood of confusion. the opponent was represented by REGIMBEAU and its proceedings were handled in English The second opposition filed on July 20, 2020 by Onderlinge Waarborgmaatschappij Centrale Zorgverzekeraars groep, Zorgverzekeraar u.a. on Likelihood of confusion. the opponent was represented by NLO SHIELDMARK B.V. and its proceedings were handled in English
The application was filed in Danish, and Danish was also language of all opposition proceedings (English was selected as the second language).
Change of name and address of the trademark registration was recorded on September 27, 2020. Change of name and address of the trademark registration was recorded on October 21, 2020.
The Appeal with reference B R1156/2022-1 was Inadmissible according to Article 68(1) EUTMR with decision issued on September 27, 2022 by the EUIPO. The Opposition with reference B 003126497 was rejected according to Article 8(1)(b) EUTMR with decision issued on May 1, 2022 by the EUIPO.
Goods And Services
The mark was filed in class 35 with Compiling data for research purposes in the field of medical science.
The mark was filed in class 36 with Providing funding in the fields of scientific medical and biomedical research and none of the above in relation to or in conjunction with health insurance or the provision of health care advice to patients..
The mark was filed in class 41 with Educational services, namely, arranging and conducting seminars, workshops, colloquia, lectures, non-downloadable webinars, multimedia presentations and training in the fields of biomedical research, biotechnology, bioinformatics, bioengineering, data analytics and data science.
The mark was filed in class 42 with following description of goods:
Scientific research in the field of medicine
Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics
Research and development of vaccines and medicines
Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines
Biotechnology research services, and research and development of new products in the field of gene therapeutics
Design of genetic research tools and systems for others
Scientific research and development, namely, development of new scientific computational technologies to predict positive and negative regulators of gene network function
Developing new technology for others in the field of computational genomics
Genome sequencing services for scientific and research purposes
Providing genetic sequencing and consulting services for clinical research purposes
Providing a website featuring blogs in the fields of biomedical research, biotechnology, bioinformatics, bioengineering, data analytics and data science
None of the aforementioned services in relation to the development and commercialization of hemostatic products based on patented biopolymers designed to simplify the surgeons' practices for open surgical procedures in numerous specialties including but not limited to cardiothoracic, abdominal and orthopedic and in laparoscopic surgeries.
The mark was filed in class 44 with following description of goods:
Genetic testing for medical purposes
Medical diagnostic testing, monitoring and reporting services
Consulting services in the fields of diagnostic medical testing
Providing genetic sequencing and consulting services for medical purposes
None of the aforementioned services in relation to the development and commercialization of hemostatic products based on patented biopolymers designed to simplify the surgeons' practices for open surgical procedures in numerous specialties including but not limited to cardiothoracic, abdominal and orthopedic and in laparoscopic surgeries.